Further, it was found that the delivery of Lv-Nrf2 exosomes inhibited AF-induced arrhythmias, myocardial fibrosis, apoptosis, and inflammation through Nrf2/HO-1 pathway triggering. The gene discussed is HMOX1; the disease is atrial fibrillation.